PEGLOTICASE

Tracking # 20-849397

$99999.00

There are no ratings for this course

Learn more

Educator STATPEARLS PUBLISHING, LLC

CE Broker Reporting Reported automatically

Method Computer-Based Training

Course overview

PEGLOTICASE IS A PEGYLATED, RECOMBINANT URICASE (URATE-OXIDASE) FDA-APPROVED IN 2010 FOR ITS USE IN THE MANAGEMENT OF CHRONIC GOUT REFRACTORY TO STANDARD THERAPY IN ADULT PATIENTS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR PEGLOTICASE AS A VALUABLE AGENT IN TREATING AND MANAGING CHRONIC GOUT REFRACTORY TO CONVENTIONAL THERAPY. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS OF PEGLOTICASE USE IN A CLINICAL SETTING, PERTINENT TO MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE CARE OF PATIENTS WITH CHRONIC GOUT AND RELATED CONDITIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I